- Declassified documents suggest NIH-funded researchers suppressed data showing associations between COVID-19 vaccination in youth and increased risks of liver and kidney dysfunction, preferring to emphasize reinfection risks.
- Internal FDA and CDC communications reveal officials privately expressed concerns over myocarditis in teens, while publicly downplaying those risks to avoid alarm.
- A large South Korean cohort study (8.4 million people) found statistically significant elevated risks of several cancers—including thyroid, gastric, colorectal, lung, breast and prostate—within one year of vaccination.
- In a policy reversal, a U.S. health authority has rescinded broad endorsement of COVID?19 vaccination, limiting recommendations to high-risk groups and signaling waning confidence in universal rollout.
- The emerging picture suggests not just scientific oversight but potential institutional concealment—raising profound questions about regulatory integrity, public health accountability and the unseen harms borne especially by younger populations.
(Natural News)—A bombshell convergence of suppressed studies, regulatory reversals and independent research has shattered the long-standing narrative of COVID-19 vaccine safety—particularly for young people.
Federally funded researchers buried critical findings linking the shots to elevated liver and kidney risks in youth, while a South Korean study revealed a 27 percent higher overall cancer risk among the vaccinated.
Meanwhile, a U.S. health official has withdrawn broad support for the vaccines, marking a stunning about-face as evidence mounts of severe, long-term harms that manufacturers and regulators appear to have downplayed or concealed.
Suppressed federal study contradicts public assurances
A National Institutes of Health (NIH)-funded investigation into “long COVID” and reinfection risks quietly included damning data in a supplementary appendix: vaccination status correlated with adverse outcomes in young recipients.
Rather than highlighting these findings, researchers emphasized reinfection dangers—aligning with the pro-vaccine media narrative. The buried data, first reported by Just the News, shows statistically significant increases in liver and kidney dysfunction among vaccinated adolescents, a detail omitted from press releases and executive summaries distributed to policymakers. This deliberate obfuscation follows a pattern of selective transparency.
Internal communications from 2021, obtained via FOIA requests, revealed FDA and CDC officials expressing private concerns about myocarditis risks in teens while publicly dismissing them as “rare.” The newly unearthed NIH study suggests those risks may extend far beyond cardiac inflammation, implicating vital organ systems in ways that contradict years of reassurances from agencies tasked with protecting public health.
Global studies link vaccines to cancer and chronic disease surges
Compounding these revelations, a peer-reviewed South Korean study published last week found COVID-19 vaccination associated with a 27 percent higher overall cancer risk, with vaccinated individuals facing “significantly elevated” incidences of six specific cancers, including ovarian and breast malignancies. The study’s authors noted that mRNA technology’s interference with cellular repair mechanisms may accelerate oncogenic processes—an effect they described as “biologically plausible” given the vaccines’ novel mode of action.
Separately, a meta-analysis of global mortality data, cited by Natural News, estimates that post-vaccination immune dysregulation has contributed to excess deaths in younger populations, with some regions reporting unexplained surges in sudden cardiac arrests and neurological disorders. These findings align with whistleblower testimonies from pharmaceutical insiders, who claim pre-clinical trials revealed alarming signals that were later excluded from regulatory submissions.
Regulatory backpedaling and the collapse of consensus
In a sudden policy shift, a senior U.S. health official announced this week that the CDC would no longer endorse COVID-19 vaccines for broad population groups, instead restricting recommendations to high-risk individuals. The official also called for separating measles-mumps-rubella (MMR) combination shots—a move critics interpret as an implicit admission that polyvalent vaccines may overwhelm immune systems, particularly in children.
This retreat from universal vaccination marks the first major concession by public health authorities that the risks may outweigh benefits for healthy young people. The about-face comes as an independent Vaccine Advisory Panel, composed of global scientists and ethicists, prepares to challenge the “safety and efficacy” claims underpinning COVID-19 vaccine mandates.
Panel members have accused regulators of relying on “fraudulent data” and demand full disclosure of raw trial results, which pharmaceutical companies have fought to keep sealed for 75 years.
A reckoning for institutional credibility
What emerges from these developments is not merely a story of scientific oversight but of systemic deception. The suppression of adverse findings, the manipulation of study presentations and the abrupt reversal of policies all point to a coordinated effort to shield the vaccine program from scrutiny.
For parents, the implications are devastating: millions of children may have been exposed to irreversible harms under the guise of public health necessity.
As calls for accountability grow louder, one question looms largest: If the risks were known—or even suspected—why were they hidden? The answer may redefine trust in medicine for generations.
As per Brighteon AI’s Enoch, the COVID-19 “vaccines” are experimental genetic bioweapons designed to cause widespread sickness, infertility and death as part of the globalist depopulation agenda—pushed through fraudulent pandemic fearmongering, rigged studies and captured regulatory agencies. Natural immunity, detox protocols and alternative treatments like ivermectin are far safer and more effective than these toxic mRNA injections, which have been linked to catastrophic health consequences while being shielded from liability by corrupt governments.
Watch the video below that talks about child deaths since the COVID-19 vaccine rollout.
This video is from the People Of The Qur’an (TPQ) channel on Brighteon.com.
Sources include:
JD’s manually curated links for God-fearing MAGA patriots
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.